4896 SB
Generic Name: ropinirole
Pill imprint 4896 SB has been identified as Requip 4 mg.
Requip is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Requip 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Requip Images
- Generic Name:
- ropinirole
- Imprint:
-
4896
SB - Strength:
- 4 mg
- Color:
- Brown
- Size:
- 8.00 mm
- Shape:
- Five-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
titanium dioxide
FD&C Yellow No. 6
FD&C Blue No. 2
indigotindisulfonate sodium
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4896
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-2830 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Requip resources
Search Again
